CAS 1802086-25-4

Gastric Inhibitory Polypeptide (3-42) (human)

CAS: 1802086-25-4

Gastric inhibitory polypeptide (3-42) represents the major physiological degradation product of gastric inhibitory polypeptide (GIP). It is generated by proteolytic processing of GIP by dipeptidyl peptidase IV (DPP IV).

Formel: C₂₁₄H₃₂₄N₅₈O₆₃S

Reinheit: 96.1%

Farbe und Form: White Powder

Molekulargewicht: 4749.35

Ref: 01-4034653

GIP (3-42), human

CAS: 1802086-25-4

Human GIP (3-42) is a peptide antagonist of GIP receptors, affecting insulin regulation and diabetes research.

Formel: C₂₁₄H₃₂₄N₅₈O₆₃S

Reinheit: 95.73%

Farbe und Form: Solid

Molekulargewicht: 4749.35

Ref: TM-T37589

GIP (3 - 42), human

CAS: 1802086-25-4

Custom research peptide; min purity 95%. For different specs please use the Peptide Quote Tool

Formel: C₂₁₄H₃₂₄N₅₈O₆₃S

Molekulargewicht: 4,749.38 g/mol

Ref: 3D-PP50414

Gastric Inhibitory Polypeptide (3-42) (human) trifluoroacetate salt

CAS: 1802086-25-4

Please enquire for more information about Gastric Inhibitory Polypeptide (3-42) (human) trifluoroacetate salt including the price, delivery time and more detailed product information at the technical inquiry form on this page

Formel: C₂₁₄H₃₂₄N₅₈O₆₃S

Reinheit: Min. 95%

Molekulargewicht: 4,749.28 g/mol

Ref: 3D-FG109902